Summary
Medtronic plc, through its indirect wholly owned subsidiary Medtronic, Inc., has successfully completed a significant debt offering, raising approximately €2.97 billion. This offering comprises four series of senior notes due in 2029, 2036, 2043, and 2053, with coupon rates ranging from 3.650% to 4.150%. These notes are fully guaranteed by Medtronic Global Holdings S.C.A. and Medtronic plc, providing an additional layer of credit support for investors. The net proceeds are intended for general corporate purposes, including the potential repayment of outstanding commercial paper and other existing indebtedness. This strategic move suggests Medtronic is actively managing its capital structure and may be refinancing existing debt, potentially at more favorable terms or extending its debt maturity profile. The company has applied to list these new notes on the New York Stock Exchange, enhancing their liquidity and accessibility for investors.
Key Highlights
- 1Medtronic plc subsidiary issued €2.97 billion in senior notes across four maturity dates (2029, 2036, 2043, 2053).
- 2The offering includes fixed coupon rates from 3.650% to 4.150%.
- 3The notes are fully and unconditionally guaranteed by Medtronic Global Holdings S.C.A. and Medtronic plc.
- 4Proceeds will be used for general corporate purposes, including potential repayment of commercial paper and other debt.
- 5The company has applied to list the notes on the New York Stock Exchange for enhanced liquidity.
- 6The debt issuance was established under a comprehensive indenture and agency agreement framework, with specific supplemental indentures executed for this offering.